Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison
- 1 September 2015
- journal article
- research article
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 32 (2) , 211-223
Abstract
To assess if enhanced stent visualization (ESV)-guided implantation of overlapping bioresorbable vascular scaffold (BVS) is superior to angiography alone-guided implantation in the reduction of overlap length. WOLFIE is a two-centre prospective open study enrolling 30 patients treated with implantation of at least two overlapping BVS. In the first centre (London), BVS implantation was guided by conventional angiography, while in the second centre (Ferrara), an ESV system was systematically employed. The primary endpoint of the study was overlap length. Secondary endpoints were: stacked struts number, area, thickness, and amount of clusters. In the ESV-guided group, overlap length was significantly lower compared to angiography-guided group [0.9 (0.6–1.8) vs. 2.2 (1.3–3.2) mm, p = 0.02]. Similarly, all secondary endpoints were significantly reduced. ESV-guided implantation of overlapping BVS is safe and effective in minimizing both overlap length and number of stacked struts.Keywords
This publication has 20 references indexed in Scilit:
- Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspectiveEuroIntervention, 2015
- Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization systemInternational Journal of Cardiology, 2015
- Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI RegistryEuroIntervention, 2015
- Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced usersNetherlands Heart Journal, 2015
- Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching ComparisonJACC: Cardiovascular Interventions, 2015
- Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular ScaffoldJACC: Cardiovascular Interventions, 2014
- Scaffold and Edge Vascular Response Following Implantation of Everolimus-Eluting Bioresorbable Vascular ScaffoldJACC: Cardiovascular Interventions, 2014
- Clinical applications of a new enhanced stent imaging technologyCatheterization and Cardiovascular Interventions, 2013
- Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trialEuropean Heart Journal, 2011
- A Cause for ConcernCirculation, 2007